Department of Urology and Renal Transplantation, La Conception University Hospital, APHM, Aix-Marseille University, 13005, Marseille, France.
Department of Urology, Nord University Hospital, APHM, Aix-Marseille University, Marseille, France.
World J Urol. 2020 Jan;38(1):159-165. doi: 10.1007/s00345-019-02768-w. Epub 2019 Apr 16.
There have recent reports in the literature of increased rates of bladder recurrence (BR) after radical nephroureterectomy (RNU) when diagnostic flexible ureteroscopy (DFU) was performed before RNU. The technical heterogeneity of DFU was a major bias in these studies. Our purpose was to evaluate the impact of a standardized DFU technique before RNU on the risk of BR.
A retrospective monocenter study including patients who underwent RNU for upper tract urothelial carcinoma (UTUC) between 2005 and 2017. 171 patients were identified. 78 patients were excluded owing to a history of bladder cancer before RNU or neo-adjuvant/adjuvant chemotherapy. 93 included patients were stratified according to pre-RNU ureteroscopy (DFU + 70 patients) or no pre-RNU ureteroscopy (DFU-23 patients). The standardized DFU technique consisted of systematic ureteral sheath (ch9-10), flexible ureteroscopy, biopsy, and drainage with a mono-J/bladder catheter to avoid contact of contaminated urine of the upper tract with the bladder.
Epidemiological, initial staging, and postoperative tumoral characteristics were similar in both groups. Mean follow-up was 35 months [2-166], 47(50%) BR occurred with 41(87%) in the DFU + group, and pre-RNU-DFU was an independent predictive factor of BR (OR = 4[1.4-11.9], P = 0.01) (Cox regression model). The characteristics of BR were similar in both groups, although BR occurred earlier in DFU + (427 days vs. 226 days (P = 0.07)).
Bladder recurrence after diagnostic ureteroscopy + nephroureterectomy was high despite technical precautions to avoid contact of bladder mucosa with contaminated urine from the upper urinary tract. Post-DFU endovesical instillation should be investigated.
文献中有报道称,在根治性肾输尿管切除术(RNU)前行诊断性软性输尿管镜检查(DFU)后,膀胱癌复发(BR)的发生率增加。这些研究中,DFU 的技术异质性是一个主要的偏倚。我们的目的是评估 RNU 前行标准化 DFU 技术对 BR 风险的影响。
这是一项回顾性单中心研究,纳入 2005 年至 2017 年间接受 RNU 治疗上尿路尿路上皮癌(UTUC)的患者。共确定了 171 例患者。78 例患者因 RNU 前膀胱癌病史或新辅助/辅助化疗而被排除。根据 RNU 前行输尿管镜检查(DFU+70 例)或未行 RNU 前行输尿管镜检查(DFU-23 例),将 93 例纳入患者进行分层。标准化 DFU 技术包括系统输尿管鞘(ch9-10)、软性输尿管镜检查、活检和引流,使用单 J/膀胱导管以避免上尿路污染尿液与膀胱接触。
两组的流行病学、初始分期和术后肿瘤特征相似。平均随访时间为 35 个月[2-166],DFU+组有 47(50%)例发生 BR,其中 41(87%)例发生在 RNU 前行 DFU 组,RNU 前行 DFU 是 BR 的独立预测因素(OR=4[1.4-11.9],P=0.01)(Cox 回归模型)。两组的 BR 特征相似,尽管 DFU+组的 BR 更早发生(427 天比 226 天,P=0.07)。
尽管采取了技术预防措施以避免膀胱黏膜与上尿路污染尿液接触,但在诊断性输尿管镜检查+肾输尿管切除术(RNU)后,膀胱癌复发率仍然很高。应研究 RNU 后行膀胱内灌洗。